Focus: Occlutech is a Switzerland-based medical device company specializing in minimally-invasive cardiac closure devices for structural heart defects and heart failure. Founded in 2003, the company operates in the cardiovascular device space with a focused product portfolio.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Occlutech to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead indication in Phase 3 development with robust clinical registry data supporting stroke prevention.
Help build intelligence for Occlutech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Occlutech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Established product in neonatal/pediatric cardiology with multi-center follow-up registries demonstrating safety and efficacy.
Novel transcatheter device addressing expanding heart failure indication with multiple clinical trials in progress.
Addresses post-surgical complication in valve replacement patients with dedicated clinical registries.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo